A therapeutic cancer vaccine is typically made from a patient’s own tumor cells or components derived from these cells. Its purpose is to trigger the immune system’s response against the unique antigens present on the tumor cells. By activating immune cells to recognize and target these antigens, the vaccine aims to not only fight the existing cancer but also establish a memory within the immune system, potentially preventing lung cancer recurrence.